October 25, 2019
PHC Holdings Corporation
TOKYO, October 25, 2019 - PHC Holdings Corporation (headquarters: Tokyo, Japan, hereafter PHC) has today announced that it has established the new Mission, Vision, and Values of the PHC Group.
The PHC Group currently offers value-added products and services across the diabetes management, diagnostics, life sciences, and healthcare service businesses. The company recently completed the acquisition of an anatomical pathology business from Thermo Fisher Scientific in June 2019 which now operates as Epredia, a new stand-alone company. In August 2019 it acquired all shares of LSI Medience Corporation based on a strategic capital alliance with Life Science Institute, Inc. This has resulted in the PHC Group evolving into a more diversified global healthcare company with over 10,000 employees across a more varied portfolio of businesses.
To better articulate this new organization, the PHC Group has unveiled a group Mission, Vision and Values to define the direction of the company and describe how it will achieve future growth ambitions. They represent the common purpose, ambitions, and principles of the entire organization, as well as the strengths and beliefs linking each group company together.
● Mission
We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people.
● Vision
Be the leading provider of best-in-class precision and digital solutions in Diagnostics and Life Sciences globally, and in Healthcare Services in Japan.
● Values
Diversity & Collaboration, Innovative Thinking, Challenging Spirit, and High Standards of Integrity.
Michael Kloss, President and CEO of PHC Holdings Corporation, explained, “The new PHC Group Mission, Vision and Values will guide how we will transform our company for future success over the coming years. They define the company we want to become and how we will to get there. Our purpose has not changed and the Mission for our company has been the foundation since PHCHD was established. The new Vision for the PHC Group brings together our current strength in precision technologies and our future aspiration to deliver best-in-class digital solutions. It also expresses our future ambition to become the leading solution provider in diagnostics and life sciences globally and in healthcare services in Japan. By applying this Mission, Vision and Values, we believe we can generate value for society, improve the lives of patients and deliver growth for our group.”
Learn more
About PHC Holdings Corporation
Incorporated in 2014, PHC Holdings Corporation is a global healthcare company with its subsidiaries including PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia and LSI Medience. Committed to its corporate mission, “We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people,” the company develops, manufactures, sells and services medical equipment and solutions across the diabetes management, diagnostics, life sciences and healthcare services. The PHC Group’s consolidated net sales in FY2018 was 186.8 billion yen with global distribution of products and services for more than 125 countries.
For further information on PHC Holdings Corporation, please visit
www.phchd.com
Media contact
Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311